These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 819359)

  • 1. The effect of antipolymorphonuclear leucocyte serum on Pseudomonas aeruginosa infection in rabbits.
    Bullen JJ; Wallis SN; Griffiths E
    Immunology; 1976 May; 30(5):603-10. PubMed ID: 819359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abolition of resistance to Klebsiella pneumoniae by anti-polymorphonuclear leucocyte IgG.
    Bullen JJ; Leach PA; Lange L
    Immunology; 1980 Jan; 39(1):47-52. PubMed ID: 6991395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of experimental Pseudomonas aeruginosa infection on the activity of mouse phagocytes.
    Izdebska-Szymona K; Nowakowska K; Sitnicka E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):511-5. PubMed ID: 6670920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of OEP-antibodies in Pseudomonas aeruginosa infection.
    Doi T; Nakajima T
    Jpn J Exp Med; 1978 Aug; 48(4):287-95. PubMed ID: 101701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of the increased resistance of mice to Pseudomonas aeruginosa caused by Staphylococcus aureus].
    Mathieu LG; deRepentigny J; Gadbois T
    Can J Microbiol; 1976 Dec; 22(12):1734-42. PubMed ID: 827329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis and intracellular killing of mucoid and nonmucoid variants of Pseudomonas aeruginosa by polymorphonuclear leukocytes: effect of specific immune sera.
    Gościniak G; Maresz-Babczyszyn J; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):467-79. PubMed ID: 6442852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis and intracellular killing of Pseudomonas aeruginosa by peritoneal macrophages of mice.
    Maresz-Babczyszyn J; Czarny A; Lagowska-Złotorzycka M
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):481-7. PubMed ID: 6442853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrastructural changes in Pseudomonas aeruginosa cells as affected by gentamycin in in vitro and in vivo experiments].
    Seleznev AS; Bykov AS
    Antibiotiki; 1983 Mar; 28(3):199-204. PubMed ID: 6407388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
    Cripps AW; Dunkley ML; Clancy RL; Kyd J
    Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a glycopolypeptide from the slime of P. aeruginosa on phagocytosis by mouse macrophages.
    Nadaud M
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):489-99. PubMed ID: 6426197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
    Speert DP; Wong SY; Macdonald M; Sargeant R
    Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of Pseudomonas aeruginosa in the peritoneal cavity of mice treated with antilymphocyte serum.
    Grogan JB
    Arch Surg; 1972 Sep; 105(3):460-3. PubMed ID: 4626868
    [No Abstract]   [Full Text] [Related]  

  • 14. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa.
    McCormick LL; Karulin AY; Schreiber JR; Greenspan NS
    J Immunol; 1997 Apr; 158(7):3474-82. PubMed ID: 9120309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes.
    Bullen JJ; Armstrong JA
    Immunology; 1979 Apr; 36(4):781-91. PubMed ID: 108208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.